This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald.
This biotech stock is set to nearly quadruple on the back of its advanced gene therapy products, says Cantor Fitzgerald
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Wall Street drifts as stocks continue to follow the bond market's leadWall Street is drifting in mixed trading, continuing a months-long run where it’s followed the cue of the bond market.
Источник: latimes - 🏆 11. / 82 Прочитайте больше »
Wall Street climbs as bond selloff eases, earnings lift moodU.S. stocks rose on Tuesday as a selloff in U.S. Treasuries eased, while upbeat forecasts from Verizon, Coca-Cola and others boosted optimism about corporate America's health in the face of slowing economy and higher inflation.
Источник: Reuters - 🏆 2. / 97 Прочитайте больше »
Wall Street climbs after profits at big companies top forecastsVerizon jumped 7% after saying it increased its number of broadband subscribers by 20% and earned more than analysts expected during the summer.
Источник: latimes - 🏆 11. / 82 Прочитайте больше »